Efficiency and tolerability of abemaciclib in elderly patients

Benzer Materyaller

• Alpelisib as a new treatment option for patients with the PIK3CA mutation. The effectiveness and tolerability of therapy on the example of a clinical case
  Yazar:: Е. I. Kovalenko, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-06-01)
• PRACTICAL ASPECTS OF ADMINISTERING CYCLIN-DEPENDENT KINASES INHIBITORS: EFFICACY AND TOLERABILITY
  Yazar:: E. V. Artamonova
  Baskı/Yayın Bilgisi: (2018-04-01)
• CDK4/6 inhibitors in the treatment of metastatic breast cancer. Choosing optimal therapy for estrogen-receptor-positive HER2-negative metastatic breast cancer: analysis of doctors’ preferences (“Prometheus”) in Russia – first results of the survey
  Yazar:: E. V. Artamonova, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-01-01)
• Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors
  Yazar:: E. V. Artamonova, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-09-01)
• Analysis of the clinical efficacy of the cyclin- dependent kinase inhibitor 4/6 Abemaciclib on the clinical case of a male with hormonereceptor- positive breast cancer
  Yazar:: А. Y. Goryainova, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-06-01)